Reino Unido - inglês - MHRA (Medicines & Healthcare Products Regulatory Agency)

bausch & lomb uk ltd - megestrol acetate - oral tablet - 160mg

Austrália - inglês - Department of Health (Therapeutic Goods Administration)

alphapharm pty ltd - famciclovir -

Austrália - inglês - Department of Health (Therapeutic Goods Administration)

sandoz pty ltd - bromocriptine mesilate, quantity: 11.5 mg (equivalent: bromocriptine, qty 10 mg) - capsule, hard - excipient ingredients: lactose monohydrate; gelatin; maize starch; colloidal anhydrous silica; magnesium stearate; maleic acid; titanium dioxide - prevention of onset of lactation in the puerperium for clearly defined medical reasons. therapy should be continued for 14 days to prevent rebound lactation. parlodel should not be used to suppress established lactation. treatment of hyperprolactinaemia where surgery and/or radiotherapy are not indicated or have already been used with incomplete resolution. precautions should be taken to ensure that the hyperprolactinaemia is not due to severe primary hypothyroidism. where the cause of hyperprolactinaemia is a prolactin-secreting microadenoma or macroadenoma, parlodel is indicated for conservative treatment; prior to surgery in order to reduce tumour size and to facilitate removal; after surgery if prolactin level is still elevated. adjunctive therapy in the management of acromegaly when: (1) the patient refuses surgery and/or radiotherapy; (2) surgery and/or radiotherapy has been unsuccessful or full effects are not expected for some months; (3) a manifestation of the acromegaly needs to be brought under con

Nova Zelândia - inglês - Medsafe (Medicines Safety Authority)

apotex nz ltd - megestrol acetate 160mg - tablet - 160 mg - active: megestrol acetate 160mg excipient: colloidal silicon dioxide croscarmellose sodium lactose monohydrate magnesium stearate microcrystalline cellulose - apo-megestrol is indicated for the palliative treatment of advanced carcinoma of the breast or endometrium (i.e. recurrent, inoperable or metastatic diseases). it should not be used in lieu of currently accepted procedures such as surgery, radiation or chemotherapy. apo-megestrol is indicated for the treatment of anorexia, cachexia, or a significant weight loss in patients with a diagnosis of acquired immunodeficiency syndrome (aids).

Nova Zelândia - inglês - Medsafe (Medicines Safety Authority)

apotex nz ltd - megestrol acetate 40mg - tablet - 40 mg - active: megestrol acetate 40mg excipient: brilliant blue fcf colloidal silicon dioxide croscarmellose sodium lactose monohydrate magnesium stearate microcrystalline cellulose - apo-megestrol is indicated for the palliative treatment of advanced carcinoma of the breast or endometrium (i.e. recurrent, inoperable or metastatic diseases). it should not be used in lieu of currently accepted procedures such as surgery, radiation or chemotherapy. apo-megestrol is indicated for the treatment of anorexia, cachexia, or a significant weight loss in patients with a diagnosis of acquired immunodeficiency syndrome (aids).

Canadá - inglês - Health Canada

pharmascience inc - famciclovir - tablet - 125mg - famciclovir 125mg - nucleosides and nucleotides

Canadá - inglês - Health Canada

pharmascience inc - famciclovir - tablet - 250mg - famciclovir 250mg - nucleosides and nucleotides

Canadá - inglês - Health Canada

pharmascience inc - famciclovir - tablet - 500mg - famciclovir 500mg - nucleosides and nucleotides

Canadá - inglês - Health Canada

dominion pharmacal - famciclovir - tablet - 125mg - famciclovir 125mg - nucleosides and nucleotides

Canadá - inglês - Health Canada

dominion pharmacal - famciclovir - tablet - 250mg - famciclovir 250mg - nucleosides and nucleotides